Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Johan Brink is active.

Publication


Featured researches published by Johan Brink.


IEEE Transactions on Nanobioscience | 2003

Influence of systematically varied nanoscale topography on the morphology of epithelial cells

Ann-Sofie Andersson; Johan Brink; Ulf Lidberg; Duncan S. Sutherland

With the knowledge that cells can react to lithographically manufactured nanometer-sized surface objects, our interest concerned whether cells would respond to surface structures of systematically increasing size. Our approach to answer this question was to fabricate surfaces with the same surface chemistry and similar surface roughness but increasing size of structural features. To fabricate large areas of patterned surfaces, required for cell culture studies, we used colloidal lithography utilizing colloidal particles as a template for surface nanostructuring. The fabricated surfaces contained hemispherical nanopillars with diameters ranging from 60 to 170 nm. Changes in cell morphology of a pancreatic epithelial cell line (AR4-2J) were studied by evaluating cell area and cell shape. The latter was studied by applying the cell shape classification method using three shape descriptors. The pancreatic cells responded in a systematic way to the surface nanostructures. The cells spread more and became more nonround when cultured on surfaces with increasing size of the topographic features.


Chapters | 2004

Conceptualizing and Measuring Modern Biotechnology

Johan Brink; Maureen McKelvey; Keith Smith

This book offers a novel insight into the economic dynamics of modern biotechnology, using examples from Europe to reflect global trends. The authors apply theoretical insight to a fundamental enigma of the modern learning society, namely, how and why the development of knowledge and ideas interact with market processes and the formation of industries and firms.


European Planning Studies | 2007

Developing Capabilities: An Analysis of Biotechnology in two Regions in Australia and Sweden

Johan Brink; Linus Dahlander; Maureen McKelvey

Abstract This article analyses whether regions develop capabilities in terms of scientific, technological and business activities within specific biotechnology areas. We take a broad definition of biotechnology, and identify four industry areas: (1) core biotechnology; (2) drugs; (3) medical technologies; (4) agriculture. Capabilities and specialization-diversification are analysed for the regions of Gothenburg in western Sweden, and Brisbane in Queensland, Australia, for the period 1997–2001. These regions are relatively ordinary, and not well-studied, biotech mega-centres. The results suggest there are positive feedback mechanisms that occur in co-located activities developing regional capabilities. Regional success within biotechnology, then, is related to the existence of all or most of the different value adding activities within a sector, as well as being reasonably diversified within related sectors. This is true for all measured industry areas, although regional capability development within core biotechnology shows signs of a relatively more disruptive pattern.


Economic Dynamics of Modern Biotechnology / McKelvey, M, Laage-Hellman, J. and Rickne, A. / Edward Elgar Publisher | 2004

The Dynamics of Regional Specialization in Modern Biotechnology: Comparing Two Regions in Sweden and Two Regions in Australia , 1977-2001

Johan Brink; Linus Dahlander; Maureen McKelvey

This book offers a novel insight into the economic dynamics of modern biotechnology, using examples from Europe to reflect global trends. The authors apply theoretical insight to a fundamental enigma of the modern learning society, namely, how and why the development of knowledge and ideas interact with market processes and the formation of industries and firms.


Creativity and Innovation Management | 2009

Capabilities and Radical Changes of the Business Models of New Bioscience Firms

Johan Brink; Magnus Holmén


Archive | 2007

Accumulation, Boundaries, Capabilities and Dynamics - Explaining Firm Growth

Johan Brink


Archive | 2007

Why do firms change? Sequences of opportunity and changes in business models and capabilities in bioscience firms

Johan Brink; Magnus Holmén


Archive | 2006

The Struggling Biotechnology Firm: Technological Regimes and Firm Performance in Sub-sectors

Johan Brink; Maureen McKelvey


Archive | 2013

Financing and privatizing a visionary research endeavor in proteonomics: The case of ProSci in Australia

Johan Brink; Tomas McKelvey


Archive | 2010

Diversity of knowledge intensive entrepreneurial firms: Struggling biotech firms despite opportunities

Tomas McKelvey; Johan Brink

Collaboration


Dive into the Johan Brink's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Linus Dahlander

Chalmers University of Technology

View shared research outputs
Top Co-Authors

Avatar

Magnus Holmén

Chalmers University of Technology

View shared research outputs
Top Co-Authors

Avatar

Tomas McKelvey

Chalmers University of Technology

View shared research outputs
Top Co-Authors

Avatar

Ann-Sofie Andersson

Chalmers University of Technology

View shared research outputs
Top Co-Authors

Avatar

Ulf Lidberg

University of Gothenburg

View shared research outputs
Top Co-Authors

Avatar

Keith Smith

University of Tasmania

View shared research outputs
Top Co-Authors

Avatar

Linus Dahlander

Chalmers University of Technology

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge